Hemangioblastoma — Trials

Hemangioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06638931	Agnostic Therapy in Rare Solid Tumors(ANTARES)	recruiting	Phase 2	28	Instituto do Cancer do Estado de São PauloOTHER	1	Apr 15, 2026	clinicaltrials
NCT00330564	Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow	terminated	Phase 2	15	M.D. Anderson Cancer CenterOTHER	1	Jun 27, 2024	clinicaltrials
NCT00052013	Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584	completed	Phase 2	11	Novartis PharmaceuticalsINDUSTRY	1	Mar 6, 2017	clinicaltrials
NCT00589784	Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Data updated 22 days agoSource updated Apr 15, 2026source: clinicaltrials